Imatinib Rechallenge Impacts GIST Survival Rate
A recent nonrandomized study has shown that imatinib rechallenge impacted the survival rate for patients with advanced or metastatic gastrointestinal stromal tumor (GIST).
A recent nonrandomized study has shown that imatinib rechallenge impacted the survival rate for patients with advanced or metastatic gastrointestinal stromal tumor (GIST).
The Life Raft Group is pleased to announce the release of the first issue of The GIST Cancer Journal, the official journal of the Life Raft Group and the first academic journal devoted solely to GIST.
The LRG helped fund research by the University of Pittsburgh Cancer Institute (UPCI) to screen a library of FDA-approved anticancer drugs that previously wouldn’t have been considered as a treatment for GIST. UPCI scientists have been surprised at [...]
There are two new treatments that may have an impact on fighting GIST – immunotherapy and MRI-guided radiation. The LRG is continually looking into new treatments for GIST.
In 2006, GIST patient Jim Mills was generous enough to share his GIST journey to the Life Raft Group.
Tamara Taggart is the cover girl for a British Columbia (BC) magazine that debuted last month.
In December, the Life Raft Group launched its “We Are the Cure” campaign to fund GIST research. I sat down with Norman to find out more about The LRG GIST research team and the campaign’s progress to date.
Accomplishments—Recent Progress: 1. Using mouse models, successfully attacked GIST with antibodies, essentially telling immune system to eat the cancer cells.
After turning 50, Rob Tanner went to the doctor in May for that checkup all men are supposed to begin getting at 50.
Over the last few months we have had our new Assistant Program Director come aboard, a long time LRG staff member get married and have a mini reunion, and Fundacion GIST Mexico reached 1,000 medical students.